विधियों की तुलना करें
चुनी हुई विधियों की आमने-सामने समीक्षा करें; भिन्नता वाली पंक्तियाँ रेखांकित हैं।
| स्वास्थ्य प्रौद्योगिकी मूल्यांकन (HTA) में लागत-प्रभावशीलता विश्लेषण× | स्वास्थ्य प्रौद्योगिकी मूल्यांकन× | |
|---|---|---|
| क्षेत्र | स्वास्थ्य सेवा प्रबंधन | स्वास्थ्य सेवा प्रबंधन |
| परिवार | Process / pipeline | Process / pipeline |
| उद्भव वर्ष≠ | 1996 | 1980 |
| प्रवर्तक≠ | Diane Meade Drummond, Michael Gold | International HTA organizations, National Institutes of Health |
| प्रकार≠ | Economic evaluation methodology | Structured assessment methodology |
| मौलिक स्रोत≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 | Goodman, C. S. (2004). HTA 101: Introduction to Health Technology Assessment (Version 1.0). National Library of Medicine, National Institutes of Health. link ↗ |
| उपनाम | CEA, Cost-Effectiveness Analysis Healthcare | HTA, Technology Assessment Healthcare |
| संबंधित | 5 | 5 |
| सारांश≠ | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. | Health Technology Assessment (HTA) is a structured, multidisciplinary approach to evaluating the clinical, economic, and societal effects of healthcare technologies (devices, drugs, procedures, systems). HTA synthesizes evidence from clinical trials, observational studies, and economic analyses to support decision-makers in adoption and reimbursement determinations. |
| ScholarGateडेटासेट ↗ |
|
|